BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 16196371)

  • 21. Tumor Handling of Early-stage Cervical Cancer: A Literature Analysis of Villoglandular Adenocarcinoma of the Cervix.
    Dietl A; Aumann K; Beckmann MW
    Anticancer Res; 2020 Jun; 40(6):3049-3053. PubMed ID: 32487598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Reevaluation for overlooked signs of cervical smears in cases of uterine cervical adenocarcinoma].
    Kutsuzawa T; Yamada Y; Ishizaki Y; Sato C; Kaneko M; Moriya S; Ichinoe K
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Dec; 36(12):2598-604. PubMed ID: 6520480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cytological check-ups after treatment of premalignant conditions in the uterine cervix].
    Nøstdahl W
    Tidsskr Nor Laegeforen; 1993 Jun; 113(15):1884-5. PubMed ID: 8322336
    [No Abstract]   [Full Text] [Related]  

  • 24. Adenoma malignum of the uterine cervix--an enigma.
    Dasgupta S; Aich RK; Deb AR; Gupta P
    J Indian Med Assoc; 2012 Dec; 110(12):929-30. PubMed ID: 23936961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Well-differentiated papillary villoglandular adenocarcinoma of the uterine cervix: a case report.
    Lu FH; Chen BF; Yang YC
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 Jul; 61(7):436-40. PubMed ID: 9699398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytologic features of well-differentiated villoglandular adenocarcinoma of the cervix.
    Ballo MS; Silverberg SG; Sidawy MK
    Acta Cytol; 1996; 40(3):536-40. PubMed ID: 8669191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary relapse of acute lymphoblastic leukemia in a cervical smear: a case report.
    Ikuta A; Saito J; Mizokami T; Asano M; Nakamoto T; Nakajima T; Matsunami M; Yasuda K; Adachi Y; Kanzaki H
    Diagn Cytopathol; 2006 Jul; 34(7):499-502. PubMed ID: 16783771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Adenocarcinoma of the endocervix. Clinical cases].
    Zarcone R; Tartaglia E; Cardone G; Voto RI
    Minerva Ginecol; 1994; 46(1-2):45-8. PubMed ID: 8177462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytologic features of endocervical glandular lesions: comparison of SurePath, ThinPrep, and conventional smear specimen preparations.
    Belsley NA; Tambouret RH; Misdraji J; Muzikansky A; Russell DK; Wilbur DC
    Diagn Cytopathol; 2008 Apr; 36(4):232-7. PubMed ID: 18335553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Invasive adenocarcinoma and related tumors of the uterine cervix.
    Young RH; Scully RE
    Semin Diagn Pathol; 1990 Aug; 7(3):205-27. PubMed ID: 2218147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Well-differentiated papillary villoglandular adenocarcinoma of the uterine cervix.
    Datta CK
    W V Med J; 1997; 93(4):186-8. PubMed ID: 9274143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytologic features of villoglandular adenocarcinoma of the uterine cervix: comparison with typical endocervical adenocarcinoma with a villoglandular component and papillary serous carcinoma.
    Chang WC; Matisic JP; Zhou C; Thomson T; Clement PB; Hayes MM
    Cancer; 1999 Feb; 87(1):5-11. PubMed ID: 10096353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microinvasive cervical adenocarcinoma (FIGO stage 1A tumors): results of surgical staging and outcome analysis.
    Ceballos KM; Shaw D; Daya D
    Am J Surg Pathol; 2006 Mar; 30(3):370-4. PubMed ID: 16538058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathological features of well-differentiated cervical adenocarcinoma with abundant mucus secretion.
    Ueki M; Ueda M; Okamura S; Yamada T
    J Med; 1995; 26(1-2):17-30. PubMed ID: 7561528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Minimal deviation adenocarcinoma of the uterine cervix.
    Chen YP; Ho SP; Liou WS; Chen CJ
    Taiwan J Obstet Gynecol; 2015 Aug; 54(4):447-9. PubMed ID: 26384069
    [No Abstract]   [Full Text] [Related]  

  • 36. Arias-Stella reaction in a cervicovaginal smear of a woman undergoing infertility treatment: a case report.
    Lui M; Boerner S
    Diagn Cytopathol; 2005 Feb; 32(2):94-6. PubMed ID: 15637674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is the ovarian preservation safe in young women with stages IB-IIA villoglandular adenocarcinoma of the uterine cervix?
    Ju UC; Kang WD; Kim SM
    J Gynecol Oncol; 2018 Jul; 29(4):e54. PubMed ID: 29770624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pelvic sidewall adenocarcinoma after definitive therapy for cervical adenocarcinoma in situ.
    Miller B; Dunn J; Dalrymple J; Krivak TC
    Gynecol Oncol; 2005 Nov; 99(2):489-92. PubMed ID: 16054200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Villoglandular adenocarcinoma of the uterine cervix: a systematic review and meta-analysis.
    Dietl AK; Beckmann MW; Aumann K
    Arch Gynecol Obstet; 2021 Aug; 304(2):317-327. PubMed ID: 34036437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lethal endometrial recurrence after cone biopsy for microinvasive cervical adenocarcinoma.
    Singh P; Scurry J; Proietto A
    J Obstet Gynaecol Res; 2008 Jun; 34(3):413-7. PubMed ID: 18588617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.